Blockade of tolerance to stress-induced analgesia by MK-801 in mice

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 3, 1997, Pages 435-439

  Vaccarino, A L ^a   Clavier, M C ^a  

^a UNIVERSITY OF NEW ORLEANS   (United States)

Author keywords

MK 801; N methyl D aspartate (NMDA); swim stress induced analgesia; tolerance

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HOT PLATE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRESS;

ANALGESIA; ANIMALS; DIZOCILPINE MALEATE; DRUG EVALUATION, PRECLINICAL; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICE; REACTION TIME; RECEPTORS, N-METHYL-D-ASPARTATE; STRESS;

ANIMALIA; SIA;

EID: 0030949423     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00235-3     Document Type: Article

References (37)

1. Akil, H.; Watson, S. J.; Young, E.; Lewis; M. E., Khachaturian, H.; Walker, M. J. Endogenous opioids: biology and function. Ann. Rev. Neurosci. 7:223-255; 1984.
2. Ben-Eliyahu, S.; Marek, P.; Vaccarino, A. L.; Mogil, J. S.; Sternberg, W. F.; Liebeskind, J. C. The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res. 575:304-308; 1992.
3. Bodnar, R. J.; Glusman, M.; Brutus, M.; Spiagga, A.; Kelly, D. D.; Analgesia induced by cold-water stress: Attenuation following hypophysectomy. Physiol. Behav. 23:53-62; 1979.
4. Bowman, W. C.; Rand, M. J. Textbook of pharmacology. Oxford: Blackwell; 1980.
5. Chesher, C. B.; Chan, B.; Whaite, C. Stress-induced analgesia in mice. In: Peck, C. L.; Wallace, M., eds. Problems in pain. Sydney: Pergamon Press; 1980:34-36.
6. Collingridge, G. L.; Bliss, T. V. P. NMDA receptors: Their role in long-term potentiation. Trends Neurosci. 10:288-294; 1987.
7. Colpaert, F. C.; Niemegeers, C. R. E.; Jansen, P. A. J.; Maroli, A. N. The effects of prior fentanyl administration and pain on fentanyl administration: Tolerance to and enhancement of narcotic analgesia. J. Pharmacol. Exp. Ther. 213:418-426; 1980.
8. Foster, A. C.; Gill, R.; Woodruff, G. N. Neuroprotective effects of MK-801 in vivo: Selectivity and evidence for delayed degeneration mediated by NMDA receptor activation. J. Neurosci. 8:4745-4754; 1988.
9. Friedman, S. B.; Ader, R.; Grota, L. J.; Larson, T. Plasma corticosterone response to parameters of electric shock stimulation in the rat. Psychosom. Med. 29:323-328; 1967.
10. Ganog, A. H.; Lanthorn, T. H.; Cotman, C. W. Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord. Brain Res. 273:170-174; 1983.
11. Guillemin, R.; Vargo, T.; Rossier, J.; Minick, S.; Ling, N.; Rivier, C.; Vale, W.; Bloom, F. Beta-endorphin and adrenocorticotrophin are released concomitantly by the pituitary gland. Science 197:1367-1369; 1977.
12. Hendrie, C. A. ACTH: A single pretreatment enhances the analgesic efficiency of and prevents the development of tolerance to morphine. Physiol. Behav. 42:41-45; 1988.
13. Holaday, J. W.; Dallman, M. F.; Loh, H. H. Effects of hypophysectomy and ACTH on opiate tolerance and physical dependence. Life Sci. 24:771-782; 1979.
14. Jacquet, Y. F. The NMDA receptor: Role in pain inhibition in rat periaqueductal gray. Eur. J. Pharmacol. 154:271-276; 1988.
15. Kim, J. J.; DeCola, J. P.; Landeira-Fernandez, J.; Fanselow, M. S.; N-methyl-D-aspartic acid receptor antagonist APV blocks aquisition but not expression of fear conditioning. Behav. Neurosci. 105:126-133; 1991.
16. Lewis, J. W.; Cannon, J. T.; Liebeskind, J. C. Opioid and non-opioid mechanisms of stress analgesia. Science 208:623-625; 1980.
17. Lewis, J. W.; Tordoff, M. G.; Sherman, J. E.; Liebeskind, J. C. Adrenal medullary enkephalin-like peptides may mediate opioid stress analgesia. Science 217:557-559; 1982.
18. Lipa, S. M.; Kavaliers, M. Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia. Brain Res. Bull. 24:627-630; 1990.
19. Lufty, K.; Hurlbut, D. E; Weber, E.; Blockade of morphine-induced analgesia and tolerance in mice by MK-801. Brain Res. 616:83-88; 1993.
20. MacRae, J. R.; Scoles, M. T.; Seigal, S; The contribution of Pavlovian conditioning to drug tolerance and dependence. Br. J. Addiction 82:371-380; 1987.
21. MacLennon, A. J.; Drugan, R. C.; Hyson, R. L.; Maier, S. F.; Madden, J; Barchas, J. D. Corticosterone: A critical factor in an opioid form of stress-induced analgesia. Science 215:1530-1532; 1982.
22. Malenka, R. C.; Nicoll, R. A. NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms. Trends Neurosci. 16:521-527; 1993.
23. Marek, P.; Ben-Eliyahu, S.; Gold, M.; Liebeskind, J. C. Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat. Brain Res. 547:77-81; 1991.
24. Marek, P.; Ben-Eliyahu, S.; Vaccarino, A. L.; Liebsekind, J. C.; Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res. 558:163-165; 1991.
25. Marek, P.; Mogil, J. S.; Sternberg, W. F.; Panocka, I.; Liebeskind, J. C. N-methyl-D-aspartic acid (NMDA) receptor antagonist MK-801 blocks non-opioid stress-induced analgesia. II. Comparison across three swim-stress paradigms in selectively bred mice. Brain Res. 578:197-203; 1992.
26. Panocka, I.; Marek, P.; Sadowski, B. Tolerance and cross-tolerance with morphine in mice selectively bred for high and low stress-induced analgesia. Pharm. Biochem. Behav. 40:283-286; 1991.
27. Pare, W. P.; Glavin, G. B. Restraint stress in biomedical research: A review. Neurosci. Biobehav. Rev. 10:339-370; 1986.
28. Siegfried, B.; Nunes de Souza, R. L. NMDA receptor blockade in the periaqueductal gray prevents stress-induced analgesia in attacked mice. Eur. J. Pharmacol. 168:239-242; 1989.
29. Swartzwelder, S.; Ferrari, C.; Anderson, W. W.; Wilson, W. A.; The drug MK-801 attenuates the development, but not the expression, of long-term potentiation and stimulus train-induced bursting in hippocampal slices. Neuropharmacology 28:441-445; 1989.
30. Takahashi, M.; Sugimachi, K.; Kaneto, H. Role of adrenal glucocorticoids in the blockade of analgesic tolerance to morphine by footshock stress exposure in mice. Jpn. J. Pharmacol. 51:329-336; 1989.
31. Tiseo, P. J.; Inturrisi, C. E. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. J. Pharmacol. Exp. Ther. 264:1090-1096; 1993.
32. Trujillo, K. A.; Akil, H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87; 1991.
33. Trujillo, K. A.; Akil, H. Inhibition of opiate tolerance and dependence by non-competitive N-methyl-D-aspartate receptor antagonists. Brain Res. 633:178-188; 1994.
34. Vaccarino, A. L.; Couret Jr., L. C. Relationship between hypothalamic-pituitary-adrenal activity and blockade of tolerance to morphine analgesia by pain: A strain comparison. Pain 63:385-389; 1995.
35. Vaccarino, A. L.; Marek, P.; Kest. B.; Ben-Eliyahu, S.; Couret, Jr., L. C.; Kao, B; Liebeskind, J. C. Morphine fails to produce tolerance when administered in the presence of formalin pain in rats. Brain Res. 627:287-290; 1993.
36. Vaccarino, A. L.; Marek, P.; Sternberg, W; Liebeskind, J. C. NMDA receptor antagonist MK-801 blocks non-opioid stress-induced analgesia in the formalin test. Pain 50:119-123; 1992.
37. Wei, E. Morphine analgesia, tolerance and physical dependence in the adrenalectomized rat. J. Pharamacol. 47:693-699; 1973.